Literature DB >> 9986887

Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.

A Tárnok1, J Hambsch, F Emmrich, U Sack, J van Son, W Bellinghausen, M Borte, P Schneider.   

Abstract

The effect of cardiopulmonary bypass (CPB) on various blood parameters in children undergoing major cardiovascular surgery was investigated in a prospective clinical study. Blood samples of children with CPB (CPB group, n = 18) or without CPB (control, n = 12) were collected before, during, and after surgery. The concentration of routine laboratory parameters, components of the complement system (C3, C4, C5, C1 inhibitor, total hemolytic complement, C3d, and C5a), circulating interleukins (IL-6 and IL-8) and soluble adhesion molecules (sICAM-1 and sE-selectin) were determined. In both groups of patients the serum concentrations of C3, C4, C5, and C1 inhibitor were significantly affected by the treatments (p < 0.001), decreased immediately after onset of anesthesia, were minimal during surgery, and increased thereafter. No significant differences in the kinetics of these parameters were detectable between CPB and control group. In the CPB group the activation of the alternative pathway (increased C3d) was found to be a specific response (p = 0.005), but also in the control group C3d and C5a concentration increased significantly (p < 0.022), indicating complement activation. None of the effects that would be expected after activation of the complement system were specific for the CPB group. In both groups the serum levels of IL-6 increased dramatically during and/or after surgery (p = 0.001), and IL-8 was detectable after surgery in 10/12 control patients. The concentration of sICAM-1 and sE-selectin decreased during surgery (p < 0.04) and later did not increase above baseline. Our data suggest that increased serum levels of inflammation mediators and increased consumption of complement and adhesion molecules occur during cardiovascular surgery. Although complement activation and ICAM-1 consumption are more pronounced in the CPB patients, none of these changes occurs exclusively in the CPB group. We conclude, therefore, that these changes are the combined effect of anesthesia, surgical trauma, and endothelial lesions. Additional, undefined CPB-induced reactions may also contribute the postoperative morbidity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9986887     DOI: 10.1007/s002469900417

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  18 in total

1.  Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery.

Authors:  Mohamed T Ghorbel; Myriam Cherif; Amir Mokhtari; Vito Domenico Bruno; Massimo Caputo; Gianni D Angelini
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

2.  Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study.

Authors:  S P Schoen; T Kittner; S Bohl; M U Braun; G Simonis; A Schmeisser; R H Strasser
Journal:  Heart       Date:  2005-11-11       Impact factor: 5.994

Review 3.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

4.  Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome.

Authors:  Jochen D Muehlschlegel; Danos C Christodoulou; David McKean; Joshua Gorham; Erica Mazaika; Mahyar Heydarpour; Grace Lee; Steven R DePalma; Tjorvi E Perry; Amanda A Fox; Stanton K Shernan; Christine E Seidman; Sary F Aranki; Jon G Seidman; Simon C Body
Journal:  Anesthesiology       Date:  2015-03       Impact factor: 7.892

5.  Does expression of a human complement-regulatory protein on xenograft cells protect them from systemic complement activation?

Authors:  Abhijit Jagdale; Huy Nguyen; Juan Li; KaLia Burnette; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Int J Surg       Date:  2020-09-25       Impact factor: 6.071

6.  Early outcomes after extracardiac conduit Fontan operation without cardiopulmonary bypass.

Authors:  Amy N McCammond; Kevin Kuo; Victoria N Parikh; Kameelah Abdullah; Raymond Balise; Frank L Hanley; Stephen J Roth
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

7.  Cytokine response in children undergoing surgery for congenital heart disease.

Authors:  Ashish B Madhok; Kaie Ojamaa; Viraga Haridas; Vincent A Parnell; Savita Pahwa; D Chowdhury
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

8.  Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass.

Authors:  Kosmas Tsakiridis; Paul Zarogoulidis; Giorgos Vretzkakis; Dimitris Mikroulis; Andreas Mpakas; Georgios Kesisis; Stamatis Arikas; Alexandros Kolettas; Giorgios Moschos; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Theodora Tsiouda; Stavros Siminelakis; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

9.  Transcatheter closure of atrial septal defect preserves right ventricular function.

Authors:  R Dhillon; M Josen; M Henein; A Redington
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

Review 10.  Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects.

Authors:  Petrus R de Jong; Alvin W L Schadenberg; Nicolaas J G Jansen; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2008-07-31       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.